Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Started: davey50, 20 Mar 2024 17:55
Last post: joey5000, 17 May 2024 19:11
I'm a naturally pessimistic person but the way this is being drawn out would point towards some value.... whether we all benefit is of course a different matter
£1m hRPC milestone figure mentioned in there, which is interesting. What happens if the company is dissolved, and fosun take hRPC to market? Are those future milestones and any royalties ever payable at that point, in the unlikely event it does get to market?
'A licence agreement with a third party has given rise to a claim of £1,000,000 in relation to a payment for achieving an hRPC milestone. The estimated-to-realise value is given as £900,000, to account for tax that make become due upon receipt of payment. The Joint Administrators are currently assessing this position and intend to shortly commence action to recover any valid amounts due'
Absolutely. As shareholders, we are bottom of the food chain, so have zero expectations at this point IMO.
Some money back, not to mention the blight of this ticker on the accounts removed, would be an improvement on the mentally 100% wipe out that was (and still is) anticipated.
Let's see. GLA while we wait for the final curtain call.
Firesale the assets left, which might cover the fees then that leaves cash around the current market cap so anybody who bought in below 4p might see a good % of their money back, everybody else however, but sometimes when you have accepted something is worth nothing getting something back feels like a bonus.
Well, perhaps they will do the honourable thing and not take too much of the 'cake' (having already drawn plentiful wages in their roles) and return a decent amount of the available cash balance to us shareholders.
Not holding my breath, and not aware of such a thing happening elsewhere before, but that would be a bonus of sorts.
Started: Narrative, 19 Mar 2024 16:36
Last post: Narrative, 20 Mar 2024 15:49
...probably not then after today's RNS.
Started: Surprised2, 5 Feb 2024 20:26
Last post: mol42, 29 Feb 2024 18:43
Evening grizzlyb
just popped in this evening, after a number of years, and whilst not surprised at all re the suspension i sincerely hope you haven't lost any money here
i remember well our discussions of old
bw for the future
and anyone else still here after all these years
jees at one point exosomes were only the icing on the cake
mol
RENE tried to raise funds last year and failed. The writing was on the wall then, if people chose not to see it then more fool them
I never understand why companies do not do a public fundraising where people can subscribe for stock at say 1.5p and see how much gets raised. I mean when HE1 raised at 0.2p everybody said game over diluted to oblivion but a short while later it 18 bags to 3.6p high. They might get £5-10 mil, so it's diluted but it gives them a chance, other stocks do not give a monkeys about doing this especially Vast who no matter how low continue to raise and dilute.
I'm sceptical this might be a fiddle when they do it this way and then flog whatever technology to management or "mates" who then disappear for a short while then refloat under a different name.
That is unnecessarily harsh. People did read the RNS. And some decided it was worth the risk to remain and see if they could get a raise or some other finance arrangement in place.
We were led to believe that they had something of value. That was clearly misleading, as evidenced by the lights out.
As I said the other day, if it were otherwise, then the BOD would have put forward a proposition to shareholders that included significant inside participation. Which, IMO, they would have got it away. I would have supported it, with the right conditions, for example.
As to the other poster's comment about the trades: no idea. It would be good to know. Especially if it was any of the RENE staff. But I guess we never will. GLA.
During thelast AGM there was a resolution giving authority to the management to dilute the stock up to 20% for a capital raise (direct/indirect), if needed.
What I don't understand is this; exactly one month ago before the last RNS 11m shares were 'traded', mainly off market. That's about 20% of the stock, with not one TR-1 form published. Okay, some retail shareholders bought or sold at the same time, but the large trades remain a mystery to me. Could they be linked to a short or some other off market financial instrument? Views anyone?
Started: waccybaccy, 23 Feb 2024 23:18
Last post: waccybaccy, 28 Feb 2024 21:40
Much appreciated!
I have added this link for info purposes.
https://companieshouse.blog.gov.uk/2019/02/27/what-does-going-into-administration-mean/
Usually eight weeks from the appointment of the administrator, so we're looking at around the end of March.
Does anyone know the timeline for the company being wound up?
Started: Balerno2, 5 Feb 2024 19:49
Last post: Taverham, 5 Feb 2024 20:00
Balerno, incorrect on both accounts. It IS NOT in administration , yet. re read the RNS. Also there is no talk of pre pack admin - that is normally when say a company has a new vehicle lined up to buy the company for a nominal amount. No talk of that. Why did you post that?
So it’s been placed into administration. It’s not a liquidation so there may be a prepack or the components will be sold off. There is a factory plus the IP. Watch this space for redundancy announcements. Given the precarious nature of the finances then these are the options where the vultures can get cheap pickings. Hope we get the forms from the administrators soon.
Started: jackdaw99, 2 Feb 2024 10:22
Last post: davey50, 5 Feb 2024 19:58
I've gone right off Pharma/Bio's just wish I had sold the lot in Agl above 35p recently instead of a %.
I wonder if the mm's knew but if they did they would have spiked it to encourage more buying.
I'll write it off then hope for a % back if they lay off all staff and get any price for parts.
Indeed. I also hope that none of them sold any shares today, or in the last week or so.
Not that the regulators would do anything anyway, if it came to it, I suspect.
They should NOT have said they had cash till end of Q1 if they knew they would need cash early for creditors.
I'm not out of pocket much, but I am annoyed this has happened so early.
I say more likely, but I guess they have spunked a fair bit to get to this point.
More likely they have retained capital to cover redundancies and creditors rather than spunking the whole lot.
Started: Allenby, 5 Feb 2024 15:16
Last post: Taverham, 5 Feb 2024 15:33
Will anyone buy the company as a going concern? Possible but chances are less than 10% imv. The chinese partner may take a look but who knows?
I’m so sorry for LTHs of which I was one once - paying several £s equivalent to today’s sp when Woodford was heavily into it. I sold out 2 years back at 44p - I couldn’t take the strain anymore. At even that sp I lost a bucketful.
Hope something turns up for you. ATB
Someone is going to pick up some very cheap patents and run with them at the expence of all us LTSH
Started: Maplinman, 5 Feb 2024 14:47
Last post: Maplinman, 5 Feb 2024 14:47
News doesn't look good. Many years ago I was into this. Feel for investors here but management has spaffed so much money away over the years. Good luck to you all.
Started: davey50, 2 Feb 2024 10:22
Last post: davey50, 2 Feb 2024 10:22
Must be tiny. For the last 2 weeks I've noticed the price jump up and down on tiny volume, one minute somebody is getting fleeced selling below the bid then the next day it's premiums being paid. Today at 3.5p offer they charge 3.6p for 60k and it's NT yet they dropped it yesterday making it out to look all terrible which I know to be bull. If this dropped positive news there is no seller or overhang to stop it, it would just take off. Could get over 4p today on any little demand as it's NT now to buy
Started: winklebelly, 1 Feb 2024 19:20
Last post: jackdaw99, 1 Feb 2024 20:27
Don't take it personally.
Share holders get another kick in the teeth.
Last post: jackdaw99, 31 Jan 2024 22:47
Https://www.theguardian.com/science/2024/jan/31/gene-therapy-hailed-as-medical-magic-wand-for-hereditary-swelling-disorder
Note that CRISPR needs a delivery system...
Started: davey50, 30 Jan 2024 12:54
Last post: grizzlyb, 31 Jan 2024 00:18
Presumably the company could run out of cash, be taken private by the directors, and then sold on. So yes, a deal could be done at the lowest possible share price. But not in the interests of the current shareholders!
If a deal gets done, presumably it will be at the lowest possible share price, i.e. as close to the deadline as possible. Is my thinking on this correct?
So yesterday people were selling way below the bid and today somebody buys 120k and pays a big premium, they are taking the mick with this stock, any interest and this will spike to 5p again. There is not that much stock to play with
Started: winklebelly, 24 Jan 2024 22:51
Last post: winklebelly, 24 Jan 2024 22:51
Heading for another low. The thing is it will be exceptionally hard for anybody to believe in Rene, rumours and bulls t no positive news nearly 10% down in one day, how long can this company carry on!
Last post: jackdaw99, 24 Jan 2024 11:47
As usual, the buy/sell indicators with this one are IMO way off-beam. Not sure how they do it but I am sure the brokers do it. So I wouldn't be at all surprised to see an increase by end of day as I still feel someone/thing is accumulating here, with a lot of patience. On the other hand I wouldn't be surprised to see the price fall by the end of the day.... c'est la vie.
Started: jackdaw99, 11 Jan 2024 16:33
Last post: Dibs61, 19 Jan 2024 15:03
OK the 25k trade 4.05p is my buy. Yes I know it’s a pure binary punt. £1k which I can write off if necessary but the upside (if it were to happen) fwiw is worth the risk imo.
I know the bear points - ie.administration quite possible
The bull points:
Iain Ross - track record in industry redx Pharma etc
Biotech sector showing signs of life?
So much R&D here - all goes to waste?
Praised by unnamed Pharma industry partner
Exosome sector due to grow substantially in coming decade with lots more R&D
We’ll see. I won’t have long to wait
... of last week's frenzy? Someone much bigger wants this and it leaked. Everyone in on the leak rushed in to get their share until they were satisfied, knowing approximately what the outcome would be. No further insiders in the know so buying stopped and now they wait. I'm hoping not for long. Fanciful, yes, but we've seen everything over the last few years...
Started: winklebelly, 16 Jan 2024 15:33
Last post: winklebelly, 16 Jan 2024 15:33
They will need more than these latest statements to make anybody believe, to much red tape surrounds Rene this company is full of broken promises.
Started: Picathartes, 12 Jan 2024 11:37
Last post: Picathartes, 12 Jan 2024 11:37
Https://www.labonline.com.au/content/life-scientist/news/exosome-based-drug-delivery-system-for-alzheimer-s-treatment-992686206
“Our study suggests that exosomes could be a promising new way to deliver drugs to the brain and treat AD,” said Professor Li Min, Associate Dean (Teaching and Learning) of Chinese Medicine at HKBU. “More research is needed, but this study provides hope that a cure for AD may be possible in the future."
Started: Picathartes, 12 Jan 2024 11:32
Last post: Picathartes, 12 Jan 2024 11:32
Https://www.nature.com/articles/s41392-023-01704-0
"Exosomes derived from stem cells (e.g., embryonic, induced pluripotent, hematopoietic, mesenchymal, neural, and endothelial stem cells) are capable of treating numerous diseases encountered in orthopedic surgery, neurosurgery, plastic surgery, general surgery, cardiothoracic surgery, urology, head and neck surgery, ophthalmology, and obstetrics and gynecology."
Started: Picathartes, 11 Jan 2024 14:27
Last post: Picathartes, 11 Jan 2024 14:27
Started: joey5000, 9 Jan 2024 19:34
Last post: joey5000, 9 Jan 2024 19:34
Probably a stupid question but any idea on why we are seeing so many tiny trades at the moment?
Started: Picathartes, 8 Jan 2024 12:32
Last post: Picathartes, 8 Jan 2024 16:28
Yeah it's worth the effort, quality bird!
Picathartes .... never seen it, but I would love to!
We still don't know the full uses of Exosomes, it's still early days but the potential is enormous. With the amazing ability to pass the Blood Brain barrier being an obvious one that could be very useful in treating a myriad of Brain disorders. Parkinsons and Alzheimers being the obvious ones.
Evidence now emerging around the rejuvination abilities of Exosomes
https://www.nature.com/articles/s41598-023-39370-5
Last post: bunsenburner123, 8 Jan 2024 07:44
RENE & TRLS both moved hard last week off cash positions. A company with considerably greater cash position vs market cap is OVB.
OVB is cash position is circa 3x greater. Worth highlighting and doing some research.
Great from RENE, I’m sure it will continue!
Either way this is the most activity in what seems like years!
I disagree, 4 weeks is long enough to raise capital, they could have been working on this in the background. But unless they have some commercial deal lined up, it's unlikely to succeed.
This is as likely to go into administration as it is to continue, if not more likely. Place your bets
In fact; 'The Directors recognise that not all of these assumed inflows are fully within the control of the Group and Company and have prepared a further plausible but downside scenario which excludes these inflows and indicates a cash runway until February 2024.'
Considering there have been minimal cash inflows, the above scenario is therefore likely and only 4 weeks away. 4 weeks is not long enough to raise sufficient capital to continue operating through issuance of new stock, therefore one might be lead to believe a deal is close.
Yes, correct FiveCandles, they tried to raise last year and didn't get enough interest. This looks like last chance saloon for them................so people should be aware and not blindly follow others into here. It's a massive risk
Last post: jackdaw99, 5 Jan 2024 11:54
RNS Number : 1234L
ReNeuron Group plc
04 September 2023
ReNeuron Group plc
("ReNeuron", the "Company" or the " Group")
R&D Update
Creating a valuable and differentiated Exosome Delivery Platform
ReNeuron Group plc (AIM: RENE), a UK based leader in stem cell derived exosome technologies, announces that it has successfully generated in vivo data to exemplify the cellular and tissue targeting capabilities of exosomes produced from its multiple conditionally immortalised producer cell lines. The Company will now look to broaden its capabilities and focus on the functional delivery of specific payloads.
Randolph Corteling, Chief Scientific Officer, commented: "I am pleased to confirm that over the last six months we have generated comparative in vivo data demonstrating distinct organ and cellular targeting capabilities of our proprietary stem-cell derived exosomes, which differentiates our CustomEX(TM) platform from that of our competitors."
Iain Ross, Executive Chairman, said: "On the basis of this data the Company will now look to broaden its capabilities and, in liaison with partners and collaborators, focus on the functional delivery of specific payloads. We look forward to updating shareholders in due course."
Started: Maplinman, 5 Jan 2024 11:00
Last post: Fredd1eboy, 5 Jan 2024 11:50
If its anything like the shares I hold, expect a placing ,after those funding it sell off at a inflated sp.....I had these dogs for years John Sinden, M Hunt days. Its a scientists gravy train....Sorry to be so negative, but Im expecting for the pitiful few I have left......classic aim...stinks of money making money, staff living off gravy train, and investors screwed.....
What a surprise....10% down from the 'pump'
If you are following 'recommendations' based on no news on BBs it's the quickest way to a loss.
"Sheep get slaughtered"
Good luck to all LTHs here
TRLS 100%+ today
This is a perennial dog. If you seriously want an undervalued share that is going to rocket this year, take a look at Seeing Machines (SEE). Next week is the CES show in the US - there will be lots of news. Before you buy DYOR, of course.
Alot of bombed out stocks - key will be at what price they raise cash, anyone know what's the story at OVB?
It does look very very cheap, doesn't mean its on a par with what AGL have just achieved...
Heading Much Higher
Looks cheap esp after Angle move 4 bag in days.
Back to 10p
Whatever it is, the company is still worth less than £3m, which is lower than the cash they have.
Hopefully something good is coming, fingers crossed.